Results for
"[search-keyword]"
Sponsor content
16 result(s) found, displaying 1 to 10
-
Australian Public Assessment Report (AusPAR)Melatonin-Link, Immela, Melakso, Voquily (melatonin) has been approved for short-term treatment of jet lag in adults aged 18 and over, and for sleep disorders in children and adolescents with neurodevelopmental disorders.
-
Australian Public Assessment Report (AusPAR)AusPAR for Trecondi for the treatment of adults with acute myeloid leukaemia or myelodysplastic syndrome, and paediatric population with malignant and non-malignant haematological diseases.
-
-
-
-
-
-
Australian Public Assessment Report (AusPAR)AusPAR for Defitelio (defibrotide) for treatment of severe hepatic veno-occlusive disease in haematopoietic stem-cell transplantation.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/sponsor/link-medical-products-pty-ltd